Some patients suffer from painful osteoarthritis very frequently, and in these cases, conventional pain therapy may be detrimental for many elderly patients. When treatment with Cartigen DUO achieves remission of pain, for continuation therapy in the remission phase, Cartigen DN may be the ideal option. This offers a low-dose management of mild to moderate pain in active osteoarthritis with options for managing the ongoing cartilage changes with glucosamine as disease modifying agent.

Presented in a strip of 10 tablets, Cartigen DN is useful in mild to moderately painful soteoarthritis with active disease.

Each film coated tablet contains Glucosamine sulfate potassium chloride USP 750 mg; Dicerein IP 50 mg; Methylsulfonylmethane USP 250 mg

 

Also Visit Our Obesity and Overweight website www.reesize .com